The Obalon® Balloon Research Study

Obalon 1-year Weight Loss Study. Open to people who are at least 30 to 50 lbs overweight and interested in treatment with the FDA-approved Obalon Balloon System to help facilitate weight loss. Insurance plans do not cover the Obalon Study Treatment. Participants will be required to pay for treatment but will be compensated for study participation.

Sign Up Today!


Sending this information is completely voluntary. Your information will be sent directly to Moore Metabolics. You should be hearing from our office within the next few days. Our team of experts will be able to give you much more information about the study and answer any questions you might have. Thank you for your interest.


The Obalon Balloon System is intended for adults with a Body Mass Index between 30 – 40. Check the chart below to see if you qualify.

*source: http://diet.mayoclinic.org

WHAT IS OBALON?

The FIRST and ONLY swallowable, FDA-approved 3-balloon system for weight loss.

The Obalon Balloon System helps facilitate weight loss by taking up space in your stomach so you eat less. Three balloons are placed for a six-month non-surgical treatment, combined with a professionally supervised nutrition and exercise program for optimal weight loss.

The Obalon 3-Balloon System helps facilitate weight loss by taking up space in your stomach so you eat less.

DO YOU QUALIFY?

The Obalon Balloon System is a swallowable intragastric balloon system indicated for temporary use to facilitate weight loss in adults with obesity (BMI of 30 – 40 kg/m2) who have failed to lose weight through diet and exercise. The System is intended to be used as an adjunct to a moderate intensity diet and behavior modification program. All balloons must be removed 6 months after the first balloon is placed.

The Obalon Balloon System is intended for adults with a Body Mass Index between 30 – 40.

While not currently covered by insurance, many physicians offer financing options to help individuals achieve their weight loss goals.
 
 

Initial Qualification Criteria

  • Adults over the age of 22
  • Body Mass Index (BMI) between 30 – 40
  • Have not had prior weight loss surgery
  • Willing to pay for treatment fees

If you are chosen as a candidate you will receive compensation for participation in the study.

THE OBALON CLINICAL TRIAL

The Obalon Balloon is an FDA-approved device for weight loss. The purpose of the study is to continue to collect weight loss and safety in participants who are getting this study treatment from their doctors. The Obalon Balloon is a non-surgical, fully-reversible device intended for weight loss. Three lightweight balloons are placed in your stomach by simply swallowing a capsule and then inflated with gas. The balloons are intended to occupy space in your stomach to help you feel fuller, eat smaller portions and lose weight. The Obalon Balloons reside in your stomach for a 6-month period and then are removed in a short, outpatient endoscopic procedure. A total of three balloons are placed over the therapy period. You will be followed for 6 additional months after the balloons are removed.

A select group of doctors are conducting a clinical trial to follow participants treated with the Obalon Balloon System for 1 year. Participants are required to pay study treatment fees but will be compensated for participation in the study also. If you participate in the Trial, you may be eligible for a discount on your therapy or be compensated for your time and travel.

If you have the will to lose the weight, we have the way.

TAKE THE NEXT STEP


Sending this information is completely voluntary. Your information will be sent directly to Moore Metabolics. You should be hearing from our office within the next few days. Our team of experts will be able to give you much more information about the study and answer any questions you might have. Thank you for your interest.